Early detection of cancer

Раннее выявление рака
Sanjiv Sam Gambhir, Kevin Michael Brindle, Lisa M. Coussens, Rebecca Claire Fitzgerald, Shankar Balasubramanian, Timothy Richard Rebbeck, Caroline Dive, Sangeeta N. Bhatia, Peter Kühn, Mark Emberton, David L. Crosby, Sadik C. Esener
2022-03-17

cancer risk assessmentclinical implementationearly cancer detectionearly detection technologiesprecancerous change
Survival improves when cancer is detected early. However, ~50% of cancers are at an advanced stage when diagnosed. Early detection of cancer or precancerous change allows early intervention to try to slow or prevent cancer development and lethality. To achieve early detection of all cancers, numerous challenges must be overcome. It is vital to better understand who is at greatest risk of developing cancer. We also need to elucidate the biology and trajectory of precancer and early cancer to identify consequential disease that requires intervention. Insights must be translated into sensitive and specific early detection technologies and be appropriately evaluated to support practical clinical implementation. Interdisciplinary collaboration is key; advances in technology and biological understanding highlight that it is time to accelerate early detection research and transform cancer survival.
1
Approximately 50% of cancers are diagnosed at an advanced stage, limiting treatment effectiveness and survival.
2
Detecting cancer or precancerous changes early could enable interventions that slow or prevent cancer progression and mortality.
3
Early detection technologies must be sensitive, specific, rigorously evaluated, and suitable for practical clinical implementation.
4
Interdisciplinary collaboration and advances in technology and biological understanding are needed to accelerate early detection research and improve cancer survival.
5
Progress requires identifying individuals at greatest cancer risk and clarifying the biology and trajectory of precancer and early cancer.

cancer and precancerous change

early detection, risk stratification, biological characterization, and clinical translation to improve cancer survival

Publication Details
Publication Date
2022-03-17
Journal
Publisher
ISSN
Cited by
1379
Access Type
Author Information
Authors
Sanjiv Sam Gambhir
Kevin Michael Brindle
Lisa M. Coussens
Rebecca Claire Fitzgerald
Shankar Balasubramanian
Timothy Richard Rebbeck
Caroline Dive
Sangeeta N. Bhatia
Peter Kühn
Mark Emberton
David L. Crosby
Sadik C. Esener
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%